{"ticker": {"uuid": "3dc23df0-d136-46ec-bb7d-d7c39a590347", "symbol": "600521", "name": "Zhejiang Huahai Pharmaceutical Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Zhejiang Huahai Pharmaceutical Co: Well-established player trading at attractive valuations", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQQ1REN0Y4YUFqQ3V4d24yZFozOXJHajhkLU04eVVvX0hXRVdlcWowd3l1a2VJNV9IN214X2dQa1dubjZVckdzeVlVd2FxNm01Q3V4V0V6OXR5VHFwWTVadEM0eC1BamYxcS0wZTJ2VGdyLTVOaFk5SDdKcm1nZmFrZzdoSm9iN2JjVklyMWhPNDQzVlozd2ZIR1hsOW40Mm5sVzFpOGEtR0RteEdjanBDWXZidGFhWk91bllyMWlvUFJPLWRSVkpn?oc=5", "source_name": "The Edge Singapore", "published_at": "2025-01-30T08:00:00+00:00", "published_display": "30 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Zhejiang Huahai Pharmaceutical Co., Ltd. Class A (SSE:600521)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiakFVX3lxTE1Pd1p0eVBGYlYtZV9GbzRtaVBEWUxNZWhvY0ZFS296c1Q3S1d6M0kydFhUS2l3M3dGdzJjeVdFdHRXWHktN2RZTmJleU1NYm9OSjJ5b0Q0bFBXZHBLa1BhaUpPQ25zR1UwZVE?oc=5", "source_name": "TradingView", "published_at": "2019-01-02T01:32:13+00:00", "published_display": "02 Jan 2019 01:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Zhejiang Huahai Pharmaceutical Co: Well-established player trading at attractive valuations", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQQ1REN0Y4YUFqQ3V4d24yZFozOXJHajhkLU04eVVvX0hXRVdlcWowd3l1a2VJNV9IN214X2dQa1dubjZVckdzeVlVd2FxNm01Q3V4V0V6OXR5VHFwWTVadEM0eC1BamYxcS0wZTJ2VGdyLTVOaFk5SDdKcm1nZmFrZzdoSm9iN2JjVklyMWhPNDQzVlozd2ZIR1hsOW40Mm5sVzFpOGEtR0RteEdjanBDWXZidGFhWk91bllyMWlvUFJPLWRSVkpn?oc=5", "source_name": "The Edge Singapore", "published_at": "2025-01-30T08:00:00+00:00", "published_display": "30 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Zhejiang Huahai Pharmaceutical Co., Ltd. Class A (SSE:600521)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiakFVX3lxTE1Pd1p0eVBGYlYtZV9GbzRtaVBEWUxNZWhvY0ZFS296c1Q3S1d6M0kydFhUS2l3M3dGdzJjeVdFdHRXWHktN2RZTmJleU1NYm9OSjJ5b0Q0bFBXZHBLa1BhaUpPQ25zR1UwZVE?oc=5", "source_name": "TradingView", "published_at": "2019-01-02T01:32:13+00:00", "published_display": "02 Jan 2019 01:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 51, "total_relevant": 2, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 2, "score": 50, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 1.1, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 16.15, "latest_week": "2026-07-17", "one_week_move": -4.1, "four_week_move": 12.5, "twelve_week_move": 3.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.447916, "market_dynamics_buy_signal": false, "relative_strength": -6.728332, "fair_value_gap": -3.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.3716, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.1% over one week, +12.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 56, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "The Edge Singapore", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.1% over one week, +12.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Zhejiang Huahai Pharmaceutical Co: Well-established player trading at attractive valuations"}], "updated_at": "2026-07-23T07:13:02.814261+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}